News tagged with monoclonal antibodies
Computer-designed proteins programmed to disarm variety of flu viruses
Computer-designed proteins are under construction to fight the flu. Researchers are demonstrating that proteins found in nature, but that do not normally bind the flu, can be engineered to act as broad-spectrum ...
13 hours ago |
5 / 5 (4) |
0
|
Nanoparticles may enhance cancer therapy
A mixture of current drugs and carbon nanoparticles shows potential to enhance treatment for head-and-neck cancers, especially when combined with radiation therapy, according to new research by Rice University ...
Nanotechnology / Bio & Medicine
Feb 16, 2012 |
5 / 5 (3) |
0
|
GOLFIG increased progression-free survival in colorectal cancer patients
Oncologists can use colorectal cancer patients' own immune system to boost the effects of chemotherapy and increase progression-free survival, according to Phase III study results presented at the AACR 102nd Annual Meeting ...
Apr 06, 2011 |
not rated yet |
0
Study identifies promising target for AIDS vaccine
A section of the AIDS virus's protein envelope once considered an improbable target for a vaccine now appears to be one of the most promising, new research by Dana-Farber Cancer Institute scientists indicates.
Medicine & Health / HIV & AIDS
Mar 31, 2011 |
5 / 5 (1) |
0
FDA approves new drug for advanced melanoma
The U.S. Food and Drug Administration today approved the use of ipilimumab for the treatment of previously treated metastatic melanoma. It is the first drug approved for metastatic, or advanced, melanoma is more than a decade.
Mar 25, 2011 |
not rated yet |
0
Life work culminates in testing of cancer therapy in humans
A cancer-fighting antibody identified by a researcher working at The University of Queensland and Queensland Institute of Medical Research (QIMR) will today be used to treat the first patient, in a Phase 1 clinical trial.
Mar 24, 2011 |
5 / 5 (2) |
0
New antibody treatments help tackle tuberculosis
Researchers from the University of Dundee, King’s College London and St George’s, University of London have identified potential new means to treat tuberculosis (TB).
Medicine & Health / Diseases, Conditions, Syndromes
Mar 01, 2011 |
not rated yet |
0
Potential treatment for Chikungunya discovered
The Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS, a French biopharmaceutical company, announced today the discovery of two new fully human monoclonal ...
Medicine & Health / Diseases, Conditions, Syndromes
Feb 16, 2011 |
5 / 5 (2) |
0
Detecting lethal diseases with rust and sand
The next big thing in medical diagnostics could be minutes particles of rust, iron oxide, coated with the material from which sand is formed, silicon dioxide. These magnetic nanoparticles, a mere 29 to 230 nanometers across, ...
Nanotechnology / Bio & Medicine
Jan 31, 2011 |
5 / 5 (2) |
0
|
Conversion of brain tumor cells into blood vessels thwarts treatment efforts
Glioblastoma, the most common and lethal form of brain cancer and the disease that killed Massachusetts Senator Ted Kennedy, resists nearly all treatment efforts, even when attacked simultaneously on several ...
Jan 24, 2011 |
5 / 5 (7) |
1
|
Detecting, treats tumors, and monitoring response to therapy with gold 'nano-popcorn'
Using a two-step process that creates gold nanoparticles that look like kernels of popcorn, researchers at Jackson State University have created a targeted nanoparticle that can detect as few as 50 malignant prostate cells ...
Nanotechnology / Bio & Medicine
Jan 19, 2011 |
3.5 / 5 (2) |
0
|
Researchers discover a potential target for therapy for patients with a deadly prostate cancer
A monoclonal antibody targeting a well known cell surface protein inhibited prostate cancer growth and metastasis in an aggressive form of the disease that did not respond to hormone therapy, according to a study by researchers ...
Nov 08, 2010 |
5 / 5 (2) |
0
|
New lymphoma therapy may be more effective with fewer side effects
Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin's lymphoma that accounts for approximately 40 percent of lymphomas among adults. If left untreated, it is fatal. The existing treatments have a cure ...
Nov 03, 2010 |
5 / 5 (2) |
0
Colorectal cancer patients with gene mutation show better response to cancer agent
Even though the cancer-treatment agent cetuximab is not considered effective treatment for KRAS (a gene)-mutated metastatic colorectal tumors, new research indicates that patients with colorectal cancer not responding to ...
Oct 26, 2010 |
not rated yet |
0
New targeted therapy adds benefit to erlotinib in some patients with advanced lung cancer
A subset of lung cancer patients seem to live longer and experience delays in disease progression when a new drug that targets a cancer-associated molecule called MET is added to treatment with erlotinib, the results of a ...
Oct 09, 2010 |
not rated yet |
0
Monoclonal antibodies
Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are identical because they are produced by one type of immune cell that are all clones of a single parent cell. Given almost any substance, it is possible to create monoclonal antibodies that specifically bind to that substance; they can then serve to detect or purify that substance. This has become an important tool in biochemistry, molecular biology and medicine. When used as medications, the generic drug name ends in -mab (see "Nomenclature of monoclonal antibodies").
For more information about Monoclonal antibodies, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
